KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current DebtOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Insulet (PODD) Liabilities and Shareholders Equity (2016 - 2025)

Insulet (PODD) has disclosed Liabilities and Shareholders Equity for 16 consecutive years, with $3.2 billion as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, Liabilities and Shareholders Equity rose 3.33% year-over-year to $3.2 billion, compared with a TTM value of $13.2 billion through Dec 2025, up 13.66%, and an annual FY2025 reading of $3.2 billion, up 3.33% over the prior year.
  • Liabilities and Shareholders Equity was $3.2 billion for Q4 2025 at Insulet, up from $3.0 billion in the prior quarter.
  • Across five years, Liabilities and Shareholders Equity topped out at $3.5 billion in Q1 2025 and bottomed at $1.8 billion in Q1 2021.
  • Average Liabilities and Shareholders Equity over 5 years is $2.5 billion, with a median of $2.4 billion recorded in 2023.
  • The sharpest move saw Liabilities and Shareholders Equity skyrocketed 66.04% in 2021, then rose 0.13% in 2025.
  • Year by year, Liabilities and Shareholders Equity stood at $2.0 billion in 2021, then grew by 9.87% to $2.3 billion in 2022, then increased by 14.97% to $2.6 billion in 2023, then rose by 19.3% to $3.1 billion in 2024, then grew by 3.33% to $3.2 billion in 2025.
  • Business Quant data shows Liabilities and Shareholders Equity for PODD at $3.2 billion in Q4 2025, $3.0 billion in Q3 2025, and $3.5 billion in Q2 2025.